174 related articles for article (PubMed ID: 35732801)
1. Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.
Zhang T; Wang Z; Liu M; Liu L; Yang X; Zhang Y; Bie J; Li Y; Ren M; Song C; Wang W; Tan H; Luo J
Oncogene; 2022 Jul; 41(29):3694-3704. PubMed ID: 35732801
[TBL] [Abstract][Full Text] [Related]
2. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
[TBL] [Abstract][Full Text] [Related]
3. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
Li Y; Li X; Fan G; Fukushi J; Matsumoto Y; Iwamoto Y; Zhu Y
Cancer Lett; 2012 Jul; 320(1):14-22. PubMed ID: 22266186
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
Selvanathan SP; Graham GT; Erkizan HV; Dirksen U; Natarajan TG; Dakic A; Yu S; Liu X; Paulsen MT; Ljungman ME; Wu CH; Lawlor ER; Üren A; Toretsky JA
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1307-16. PubMed ID: 25737553
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
6. EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
Gorthi A; Romero JC; Loranc E; Cao L; Lawrence LA; Goodale E; Iniguez AB; Bernard X; Masamsetti VP; Roston S; Lawlor ER; Toretsky JA; Stegmaier K; Lessnick SL; Chen Y; Bishop AJR
Nature; 2018 Mar; 555(7696):387-391. PubMed ID: 29513652
[TBL] [Abstract][Full Text] [Related]
7. HNRNPH1-dependent splicing of a fusion oncogene reveals a targetable RNA G-quadruplex interaction.
Neckles C; Boer RE; Aboreden N; Cross AM; Walker RL; Kim BH; Kim S; Schneekloth JS; Caplen NJ
RNA; 2019 Dec; 25(12):1731-1750. PubMed ID: 31511320
[TBL] [Abstract][Full Text] [Related]
8. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
Grohar PJ; Kim S; Rangel Rivera GO; Sen N; Haddock S; Harlow ML; Maloney NK; Zhu J; O'Neill M; Jones TL; Huppi K; Grandin M; Gehlhaus K; Klumpp-Thomas CA; Buehler E; Helman LJ; Martin SE; Caplen NJ
Cell Rep; 2016 Jan; 14(3):598-610. PubMed ID: 26776507
[TBL] [Abstract][Full Text] [Related]
9. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
10. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel translocation producing an in-frame fusion of TAF15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period.
Picard C; Macagno N; Corradini N; Marec-Bérard P; Cabet S; Guibaud L; Viremouneix L; Raux S; Chotel F; Weinbreck N; Meurgey A; Karanian M; Pissaloux D; Tirode F; Dijoud F
Virchows Arch; 2022 Oct; 481(4):665-669. PubMed ID: 35527322
[TBL] [Abstract][Full Text] [Related]
12. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
[TBL] [Abstract][Full Text] [Related]
13. RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.
Sánchez-Molina S; Figuerola-Bou E; Blanco E; Sánchez-Jiménez M; Táboas P; Gómez S; Ballaré C; García-Domínguez DJ; Prada E; Hontecillas-Prieto L; M Carcaboso Á; Tirado ÓM; Hernández-Muñoz I; de Álava E; Lavarino C; Di Croce L; Mora J
Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33097530
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.
García-Domínguez DJ; Hajji N; Sánchez-Molina S; Figuerola-Bou E; de Pablos RM; Espinosa-Oliva AM; Andrés-León E; Terrón-Camero LC; Flores-Campos R; Pascual-Pasto G; Robles MJ; Machado I; Llombart-Bosch A; Magagnoli G; Scotlandi K; Carcaboso ÁM; Mora J; de Álava E; Hontecillas-Prieto L
Oncogene; 2021 Sep; 40(39):5843-5853. PubMed ID: 34345016
[TBL] [Abstract][Full Text] [Related]
15. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
16. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
[TBL] [Abstract][Full Text] [Related]
17. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution.
Aynaud MM; Mirabeau O; Gruel N; Grossetête S; Boeva V; Durand S; Surdez D; Saulnier O; Zaïdi S; Gribkova S; Fouché A; Kairov U; Raynal V; Tirode F; Grünewald TGP; Bohec M; Baulande S; Janoueix-Lerosey I; Vert JP; Barillot E; Delattre O; Zinovyev A
Cell Rep; 2020 Feb; 30(6):1767-1779.e6. PubMed ID: 32049009
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma.
Sankar S; Bell R; Stephens B; Zhuo R; Sharma S; Bearss DJ; Lessnick SL
Oncogene; 2013 Oct; 32(42):5089-100. PubMed ID: 23178492
[TBL] [Abstract][Full Text] [Related]
20. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
